Marinomed Biotech AG (VIE:MARI)
Austria
· Delayed Price · Currency is EUR 14.00
-0.05 (-0.36%)
Mar 31, 2025, 5:49 PM CET
Marinomed Biotech AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 6.42 | 9.18 | 11.28 | 11.63 | 8.12 | 6.14 | Upgrade
|
| Other Revenue | - | - | - | - | - | 0.6 | Upgrade
|
| Revenue | 6.42 | 9.18 | 11.28 | 11.63 | 8.12 | 6.75 | Upgrade
|
| Revenue Growth (YoY) | -44.69% | -18.56% | -3.03% | 43.12% | 20.43% | 35.46% | Upgrade
|
| Cost of Revenue | 5.67 | 8.33 | 9.4 | 10.43 | 8.92 | 6.73 | Upgrade
|
| Gross Profit | 0.75 | 0.86 | 1.88 | 1.2 | -0.79 | 0.02 | Upgrade
|
| Selling, General & Admin | 5.34 | 5.29 | 5.13 | 4.83 | 4.37 | 4.22 | Upgrade
|
| Other Operating Expenses | 0.99 | 1.07 | 1.36 | 1.42 | 1.39 | 1.76 | Upgrade
|
| Operating Expenses | 6.99 | 7.04 | 7.16 | 6.86 | 6.18 | 6.3 | Upgrade
|
| Operating Income | -6.25 | -6.18 | -5.28 | -5.66 | -6.98 | -6.29 | Upgrade
|
| Interest Expense | -3.18 | -2.49 | -2.51 | -1.51 | -0.71 | -0.67 | Upgrade
|
| Interest & Investment Income | - | 0.04 | 0.04 | 0.06 | 0.05 | 0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.45 | 0.82 | 1.11 | -0.04 | 0.53 | -0.34 | Upgrade
|
| EBT Excluding Unusual Items | -14.88 | -7.8 | -6.64 | -7.15 | -7.1 | -7.21 | Upgrade
|
| Other Unusual Items | 0.76 | 1.01 | 0.24 | 1.45 | 1.1 | -0 | Upgrade
|
| Pretax Income | -14.11 | -6.79 | -6.39 | -5.69 | -6.01 | -7.21 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0.01 | 0.2 | 0 | 0 | Upgrade
|
| Net Income | -14.12 | -6.79 | -6.4 | -5.89 | -6.01 | -7.22 | Upgrade
|
| Net Income to Common | -14.12 | -6.79 | -6.4 | -5.89 | -6.01 | -7.22 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 2 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | -0.40% | 1.29% | 1.56% | 0.31% | 3.75% | 41.81% | Upgrade
|
| EPS (Basic) | -9.30 | -4.48 | -4.27 | -3.99 | -4.09 | -5.09 | Upgrade
|
| EPS (Diluted) | -9.33 | -4.50 | -4.30 | -4.00 | -4.10 | -5.10 | Upgrade
|
| Free Cash Flow | -4.15 | -4.66 | -5.43 | -5.79 | -10.85 | -9.98 | Upgrade
|
| Free Cash Flow Per Share | -2.73 | -3.07 | -3.62 | -3.92 | -7.37 | -7.04 | Upgrade
|
| Gross Margin | 11.61% | 9.33% | 16.68% | 10.32% | -9.77% | 0.24% | Upgrade
|
| Operating Margin | -97.29% | -67.27% | -46.86% | -48.67% | -85.88% | -93.17% | Upgrade
|
| Profit Margin | -219.93% | -73.99% | -56.74% | -50.67% | -73.98% | -106.97% | Upgrade
|
| Free Cash Flow Margin | -64.62% | -50.71% | -48.16% | -49.75% | -133.53% | -147.95% | Upgrade
|
| EBITDA | -5.86 | -5.77 | -4.89 | -5.28 | -6.79 | -6.21 | Upgrade
|
| EBITDA Margin | -91.25% | -62.88% | -43.39% | -45.42% | -83.62% | -91.98% | Upgrade
|
| D&A For EBITDA | 0.39 | 0.4 | 0.39 | 0.38 | 0.18 | 0.08 | Upgrade
|
| EBIT | -6.25 | -6.18 | -5.28 | -5.66 | -6.98 | -6.29 | Upgrade
|
| EBIT Margin | -97.29% | -67.27% | -46.86% | -48.67% | -85.88% | -93.17% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.